U.S. federal trademark · Serial No. 99057385
Pharmaceutical products for the treatment of cystic fibrosis, type 2 diabetes, dry eye disease, lipid imbalances, sickle cell disease and hypertriglyceridemia; pharmaceutical products containing fatty acid blends for the treatment of cystic fibrosis, type 2 diabetes, dry eye disease, lipid imbalances, sickle cell disease and hypertriglyceridemia; pharmaceutical products for the treatment of lipid imbalances; pharmaceutical products for the treatment of sickle cell disease
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.